NanoMedicine
Nanotechnology for Enhancing Human Health
 |
|---|
James Baker, M.D.
Director, Nanotechnology Institute For Medicine & the Biological Sciences
University of Michigan
10:30 a.m., Red Auditorium
The application of nanotechnology to the prevention and treatment of human diseases holds great promise, but nanomaterials must be biocompatible, non-toxic and functional in biologic (wet) conditions, and well enough defined for acceptance by regulatory agencies. Early applications of nanomaterials will likely involve the development of medications that take advantage of unique aspects of nanostructures to achieve or enhance therapeutic activity. Examples will be given for the design, synthesis, and analysis of nanomaterials having attached molecules that allow for unique therapeutic functions. Applications include antimicrobial compounds, drug and gene delivery, and functional imaging. Concepts for future applications such as cellular engineering, human performance augmentation, and genetic manipulation for treating human disease will be presented.
Anyone outside NIST wishing to attend must be sponsored by a NIST employee and receive a visitor badge.
For more information, call Kum J. Ham at 301-975-4203. Colloquia are videotaped and available in the NIST Research Library.